Related Experiment Video
Updated: Oct 30, 2025

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
Testing physiologically relevant conditions in minimal inhibitory concentration assays
Corrie R Belanger1, Robert E W Hancock2
1Centre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada.
This study presents a modified minimal inhibitory concentration (MIC) assay for antimicrobial susceptibility testing. The enhanced broth microdilution method uses physiologically relevant media, improving clinical accuracy for bacterial infections.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Minimal inhibitory concentration (MIC) assays are standard for antimicrobial susceptibility testing.
- Traditional MIC assays use laboratory media, which may not reflect in vivo conditions.
- There is a need for MIC assays that better mimic clinical infection environments.
Purpose of the Study:
- To adapt the MIC broth microdilution assay for use with physiologically relevant media.
- To provide a protocol for preparing media mimicking clinical conditions like lung exudate, wound exudate, or blood.
- To enable more accurate antimicrobial susceptibility testing for clinical pathogens.
Main Methods:
- The study extends a previous protocol for MIC assays.
- A platform for preparing custom media is described.
- The MIC broth microdilution assay is applied using these tailored media.
Main Results:
- The developed method allows for antimicrobial susceptibility testing in media that mimic in vivo conditions.
- The protocol is applicable to ESKAPE pathogens and other aerobic pathogens.
- The assay can be completed within 3-4 days.
Conclusions:
- This enhanced MIC assay provides a more clinically relevant method for determining antimicrobial susceptibility.
- The protocol facilitates testing against pathogens in conditions closer to those found in patients.
- This approach can aid in the development and application of novel antimicrobial drugs.
More Related Videos
06:36Establishing the Minimal Bactericidal Concentration of an Antimicrobial Agent for Planktonic Cells MBC-P and Biofilm Cells MBC-B
Published on: January 2, 2014
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017